<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">

    <channel>
    
    <title><![CDATA[News]]></title>
    <link>/de/company/news/</link>
    <description></description>
    <dc:language>de</dc:language>
    <dc:creator>susanne.kreuter@spacelabs.com</dc:creator>
    <dc:rights>Copyright 2011</dc:rights>
    <dc:date>2011-11-09T17:43:48+00:00</dc:date>
    <admin:generatorAgent rdf:resource="http://expressionengine.com/" />
    

    <item>
      <title><![CDATA[Spacelabs Healthcare to Unveil New Technologies at MEDICA 2011 - Advanced Anaesthesia, Patient Monitoring and Diagnostic Cardiology Solutions]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-to-unveil-new-technologies-at-medica-2011-advanced-ana</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-to-unveil-new-technologies-at-medica-2011-advanced-ana#When:17:43:48Z</guid>
      <description><![CDATA[Spacelabs Healthcare, an international developer, manufacturer and distributor of medical equipment and services will have a major presence in Düsseldorf next week at MEDICA 2011, as the company unveils a wide array of new technologies at the world’s largest healthcare trade fair. Demonstrations of the following new products will be held November 16-19 in Hall 11 # E39:

• ArkonTM (510(k) clearance pending) – High-performance anesthesia delivery system designed to work the way anesthesiologists work –&nbsp; so that the focus is on the patient, not the machine
• XprezzonTM – Patient monitoring system that delivers innovative technology and design to shape the new age of care for clinicians and patients alike
• ICS XprezzTM  – Mobile app for iPad providing clinicians with up-to-the-minute views of waveform or numeric data in the palms of their hands
• Pathfinder® SL – Holter analysis solution that delivers innovative technology, rapid analysis and enhanced accuracy in the exploration of a patient’s cardiac condition
• Multigas Module – incorporating the PHASEIN gas analysis bench and NOMOLINETM (no-moisture) gas sampling line, for increased performance and reliability in monitoring CO2, N2O, O2 and anesthetic agents on all patient populations, from newborn through adult

“MEDICA provides an optimal venue to share our latest technology with healthcare providers worldwide,” said Nicholas Ong, President of Spacelabs Healthcare.

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-11-09T17:43:48+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Rated #1 in Holter Monitoring]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-rated-1-in-holter-monitoring</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-rated-1-in-holter-monitoring#When:17:30:57Z</guid>
      <description><![CDATA[According to MD Buyline’s third quarter 2011 report, Spacelabs Healthcare is  ranked #1 in overall customer satisfaction – having earned the industry’s highest rating in all categories, including product performance, reliability, installation, implementation and applications training, as well as service response time and service repair quality – as related to Holter Monitoring solutions. 

“It is gratifying to know that users of our Holter monitoring solutions rank us highest in every category”, said Nicholas Ong, President of Spacelabs Healthcare. “This indicates to me that we are achieving our mission, which is to inspire the world to bring the best care experience to patient and families, one patient, one family, one smile at a time.”

Spacelabs Healthcare (as Delmar Reynolds) invented Holter technology more than 40 years ago. Today Spacelabs Healthcare offers a full line of non-invasive diagnostic cardiology solutions – from state-of-the-art 7 day Holter recorders and analyzers  – to Cardiology Information Management Systems that coordinate and store results from a range of non-invasive procedures.

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-11-01T17:30:57+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Introduces New Multigas Module - Speed and Performance in a Small Package]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-introduces-new-multigas-module-speed-and-performance-i</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-introduces-new-multigas-module-speed-and-performance-i#When:17:40:42Z</guid>
      <description><![CDATA[Spacelabs Healthcare is introducing a new Multigas Module that can identify and display agent values in less than 20 seconds, and is suitable for use on all patient populations – from newborn through adult – due to its low sample flow rate (50 ml/min). Capable of integrating directly into Spacelabs patient monitoring systems, the new Multigas Module incorporates advanced technology – including the PHASEIN gas analysis bench and NOMOLINETM (no-moisture) gas sampling line – for increased performance and reliability in monitoring CO2, N2O, O2 and anesthetic agents. 

“Spacelabs’ new Multigas Module provides clinicians with the information they need – quickly, accurately and reliably – to provide all of their patients, from infants to adults, with the very best patient care”, said Nicholas Ong, President of Spacelabs Healthcare.

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-10-14T17:40:42+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Awarded Novation Contract For Patient Monitoring & Connectivity Solutions]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-awarded-novation-contract-for-patient-monitoring-conne</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-awarded-novation-contract-for-patient-monitoring-conne#When:17:38:16Z</guid>
      <description><![CDATA[Spacelabs Healthcare, a leading innovator of patient monitoring and connectivity solutions, today announced that it has been awarded a three-year contract to provide its complete line of patient monitoring solutions to the VHA, UHC, and Provista members served by Novation, a leading healthcare supply contracting company. This new agreement begins Dec. 1, 2011, and has two one-year extension options.

Spacelabs Healthcare’s accurate, reliable, and easy-to-use patient monitoring and connectivity solutions offer fast access to comprehensive patient information when and where needed to support decisions which, in turn, can improve response time, advance patient care, and enhance patient safety. For instance, clinicians on the go can have complete access to patient information including near-live waveforms and graphical trends on their iPads or other mobile devices thanks to ICS Xprezz, Spacelabs Healthcare’s new mobile app for iPad.&nbsp; 
“Novation has our ongoing commitment to provide innovative technologies that help improve efficiencies, increase profitability, and enhance patient outcomes for the members it serves,” said Nicholas Ong, President of Spacelabs Healthcare.

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-10-12T17:38:16+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare to Unveil New Technologies at ASA 2011]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-to-unveil-new-technologies-at-asa-2011</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-to-unveil-new-technologies-at-asa-2011#When:17:33:03Z</guid>
      <description><![CDATA[Sixty years of anesthesia delivery and ventilation expertise will culminate in the introduction of an array of new products from Spacelabs Healthcare at the American Society of Anesthesiologists meeting, October 15-19, in Chicago.&nbsp; Arkon, a new high-performance anesthesia system, will be at the forefront, paired with the popular Xprezzon patient monitor and a new Multigas Analyzer. Spacelabs Healthcare will also introduce the latest BleaseFocus for the first time to the North American market.

“Our goal is to help anesthesiologists achieve that perfect balance between practice and patient, by providing tools that are intuitive and flexible so that their focus can always be on the patient,” said Nicholas Ong, President of Spacelabs Healthcare.

Spacelabs Healthcare has a rich history of innovation in the perioperative environment. Over the years, the company has introduced many “firsts”, such as the first anesthesia ventilator to integrate spirometry loops and the first maintenance-free vaporizer. Today, Spacelabs Healthcare’s perioperative research and development center, based in Madison, Wisconsin, is comprised of a team of engineers with over 200 years of combined experience in the design and development of related products.

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-10-11T17:33:03+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Launches ICS Xprezz™ New Application Brings ICS G2 Clinical Tools to the iPad®]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-ics-xprezz-new-application-brings-ics-g2-clin</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-ics-xprezz-new-application-brings-ics-g2-clin#When:21:01:06Z</guid>
      <description><![CDATA[Spacelabs Healthcare, a pioneer of patient monitoring and connectivity solutions,&nbsp; today announced the newest addition to the Xprezzon™ monitoring line – ICS Xprezz – a mobile application for the iPad. Building on Spacelabs’ commitment to clinical partners, ICS Xprezz adds a new dimension in providing the best care experience for patients and their families. 

ICS Xprezz provides the revolutionary ability for clinicians to view their patients’ comprehensive monitoring information anywhere they have mobile access. Whether inside the hospital or on the go, clinicians can now have up-to-the-minute views of any waveform or numeric data captured on the XPREZZON monitor, in the palm of their hand. With ICS Xprezz clinicians can have the confidence of always being near their patients, and the freedom to respond quickly from wherever they happen to be.
 
“ICS Xprezz provides caregivers with a wealth of patient information on their iPad”, said Nicholas Ong, President of Spacelabs Healthcare. “With ICS Xprezz we take providing care at anytime, from anywhere, to a level not possible before. We present clinicians with the information they need to care for their patients, wherever they are.”
 
A natural concern of healthcare providers is security of patient data. With ICS Xprezz, Protected Health Information (PHI) can remain secure because information is processed within the hospital&#8217;s secure infrastructure, and then presented to the clinician through ICS Xprezz. Patient data is never processed or saved on the iPad, due to Spacelabs’ unique architecture and design.
 
Spacelabs encourages all clinicians with iPads to download and experience the freedom that ICS Xprezz can provide. Experience the power of viewing your patient information with an application optimized for a touch screen mobile device. 
 
ICS Xprezz is now available to download from the Apple® App Store. To download, follow this link: http://itunes.apple.com/us/artist/spacelabs-healthcare-llc/id434433928?uo=4]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-07-11T21:01:06+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Launches Encore High Performance Fetal/Maternal Monitor]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-encore-high-performance-fetal-maternal-monito</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-encore-high-performance-fetal-maternal-monito#When:19:13:15Z</guid>
      <description><![CDATA[Spacelabs Healthcare, a pioneer of patient monitoring &amp; connectivity solutions, today announced the introduction of the Sonicaid Encore, a high performance fetal and maternal intrapartum monitor that uses today’s most advanced technology for patient monitoring in labor and delivery.
 
“The labor and delivery environment can be stressful and situations can change rapidly”, said Nicholas Ong, President of Spacelabs Healthcare.&nbsp; “The Encore monitor delivers the high performance needed to provide continuous, reliable monitoring of both mother and fetus.”
 
Encore uses today’s most advanced ultrasound technology to enable clinicians to quickly and easily locate and track the fetal heartbeat, minimizing the need for direct fetal ECG monitoring. Further, the advanced design and high sensitivity of the toco transducer enable uterine activity monitoring for patients of all sizes, including those with high BMI, minimizing the need for intrauterine pressure monitoring.
 
As with other Spacelabs monitors Encore provides excellent connectivity. Both serial and LAN interfaces are available for most central recording and obstetrical data management systems.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-06-27T19:13:15+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Launches XPREZZON - Reaching New Heights in Patient Monitoring & Connectivity]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-xprezzon-reaching-new-heights-in-patient-moni</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-xprezzon-reaching-new-heights-in-patient-moni#When:21:03:34Z</guid>
      <description><![CDATA[Issaquah, Wash., April 19, 2011 – Spacelabs Healthcare, which decades ago pioneered medical telemetry to monitor the vital signs of orbiting astronauts, today announced the launch of XPREZZON, a patient monitoring solution that delivers innovative technology and design to shape the new age of care for clinicians and patients alike.

“The future of connecting caregivers with patient information starts here,” said Nicholas Ong, President of Spacelabs Healthcare. “The XPREZZON patient monitoring solution is the beginning of a new platform of monitoring solutions from Spacelabs Healthcare. XPREZZON expands upon our rich history and expertise in connectivity to provide caregivers with quick and complete access to critical information, anywhere and anytime they have mobile access. XPREZZON also supports our customers’ prior investments through full compatibility and connectivity to our existing Ultraview SL Patient Monitors and ICS G2 Clinical Access Suite.”
 
XPREZZON provides clinicians with more advanced features and tools to enhance patient care. For instance, visually rich custom trends can be accessed with a single touch, or they can be displayed continuously to enable faster and better informed patient assessment. Also, highly visible alarm lights illuminating front and back aid the caregiver’s ability to identify which monitor is alarming in the busy care area. In addition, the sleek, frameless display makes cleaning easier in order to minimize the risk of infection.
 
Most importantly, XPREZZON was designed with the patient in mind. XPREZZON is the first patient monitor to be sensitive to a patient’s need for a good night’s rest, intuitively dimming its display in low ambient light. Also, its overall modern design provides an appealing and comfortable experience for both patient and family.

To learn more about XPREZZON, view the following video:XPREZZON (high - bandwith)
XPREZZON (med - bandwith)
XPREZZON (low - bandwith)

Or visit Spacelabs Healthcare in Booth 2829 at AACN 2011 NTI®, May 3-5 in Chicago.
 
Contact Information
Ross Garland
Email address: ross.garland@spacelabs.com
Phone number: 425-657-7200 x4000]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-04-27T21:03:34+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[IMV Ranks Spacelabs Healthcare Best for Overall Service Performance among Industry Peers for Second Consecutive Year and Three o]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/imv-ranks-spacelabs-healthcare-best-for-overall-service-performance-among-i</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/imv-ranks-spacelabs-healthcare-best-for-overall-service-performance-among-i#When:21:25:33Z</guid>
      <description><![CDATA[Spacelabs Healthcare Maintains Top Ranking as Highest in Overall Service Performance According to the Industry’s Top Independent Survey
 
IMV Ranks Spacelabs Healthcare Best for Overall Service Performance among Industry Peers for Second Consecutive Year and Three of the last Four Years
 
Issaquah, Wash., January 4, 2011&#8212;Spacelabs Healthcare, a pioneer in the field of patient monitoring, announced that the company leads the industry in overall service performance for the second straight year. The 2010 ServiceTrak™ Patient Monitoring Systems survey by market research firm IMV Ltd., found that Spacelabs Healthcare again ranks first in the industry in Overall Service Performance.

According to IMV, “Spacelabs 2010 rating for overall OEM service performance remains top ranked in the industry” and received the highest percentage of highly satisfied customers in the following key attributes: Overall OEM Service Performance, Overall Phone Support performance, Overall Depot Service Performance and Overall Service Engineer Performance.
 
“This ranking reflects the dedication we have to our customers,” said Joe Davin, Group President, Spacelabs Healthcare. “Spacelabs Healthcare is delighted that our service team exemplifies our customer-first philosophy.”
 
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
 
SOURCE:&nbsp; Spacelabs Healthcare

Spacelabs Healthcare
Steve Phillips
Vice President, Global Service
425-657-7200
Steve.Phillips@spacelabs.com

]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-03-16T21:25:33+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Launches Enhanced Flow Meter Visualization on its BleaseSirius Anesthesia System]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-enhanced-flow-meter-visualization-on-its-blea</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-launches-enhanced-flow-meter-visualization-on-its-blea#When:21:24:33Z</guid>
      <description><![CDATA[SPACELABS HEALTHCARE LAUNCHES ENHANCED FLOW METER VISUALIZATION

Issaquah, Wash., March 7, 2011 – Spacelabs Healthcare announced today that it has received FDA 510k clearance for Enhanced Flow Meter Visualization on its BleaseSirius Anesthesia System.&nbsp; 

Identifying key information quickly and easily is critical to the anesthesia delivery practice and the ability to record and retrieve this data is also increasingly important. With traditional flow control for the Electronic Gas Flow Measurements, clinicians retain the current “touch &amp; feel” they are accustomed to. The exact digital readout for each individual gas is displayed using 3D flow tubes and numerics, making for an easy to read format. Furthermore, the dedicated display is positioned where clinicians would find traditional flow tubes, allowing them to instantly know the fresh gas flow to their patient. This data is immediately available for export to a patient monitoring system or electronic medical record.

“Spacelabs Anesthesia Systems, including the new BleaseSirius, incorporate the latest technology offering clinicians unparalleled performance in ventilation and vaporization,” said Nicholas Ong, Group President, Spacelabs Healthcare. “Focusing on the patient and clinician to machine relationship has allowed us to offer clinicians integrated technology, reduced cost of ownership and clinical ease of use.”


About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s BleaseSirius product. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.


Source:&nbsp; Spacelabs Healthcare]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2011-03-16T21:24:33+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare’s élance Patient Monitor Selected for Chilean Miner Special Rescue Care]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcares-elance-patient-monitor-selected-for-chilean-miner-spe</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcares-elance-patient-monitor-selected-for-chilean-miner-spe#When:21:25:34Z</guid>
      <description><![CDATA[Issaquah, Wash., November 30, 2010&#8212;Spacelabs Healthcare announced that the Company’s élance™ line of patient monitors played a vital role as part of the rescue operation of the 33 Chilean miners. The men were transported by helicopter to Chile’s Hospital de Copiapó, where their vital signs were tracked by the élance.

Dante Cifuentes, Spacelabs Healthcare’s Managing Director of Latin America, said, “We take special pride in the role the élance patient monitor played in this historic rescue operation. The monitor’s ease of use, reliability and versatility served the hospital well at a critical time.”

Nicholas Ong, Group President, Spacelabs Healthcare, commented: “This is a living example of the commitment of the Spacelabs mission&#8212;connecting innovation with care, not just in this dramatic rescue story but in the everyday lives of patients around the world.”

About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company&#8217;s expectations, goals or intentions about the future, including, the Company&#8217;s contracts to deliver a broad range of solutions to customers in the healthcare industry. The actual results may differ materially from those described in or implied by any forward-looking statement.
 
SOURCE: Spacelabs Healthcare

Spacelabs Healthcare
Ross Garland

Vice President, Marketing
425-657-7200
Ross.Garland@spacelabs.com]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-12-03T21:25:34+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[New Spacelabs Healthcare Dual Display Monitor Launches]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/new-spacelabs-healthcare-dual-display-monitor-launches</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/new-spacelabs-healthcare-dual-display-monitor-launches#When:21:39:15Z</guid>
      <description><![CDATA[For immediate releaseNew Spacelabs Healthcare Dual Display Monitor Delivers Patient Monitoring &amp; Workstation Performance in a Single, Cost-Effective Package
 
Issaquah, Wash., April 23, 2010 – Spacelabs Healthcare expands its patient monitoring portfolio by introducing the Ultraview 2900 with dual display capability. Clinicians can now simply and efficiently chart and access lab results on one display, while the other display remains dedicated to their patients’ real-time physiologic waveforms and alarms. With easy and immediate access to comprehensive information at the bedside monitor, there is no expensive workstation to purchase and maintain, plus there is less opportunity for infectious organisms to travel from bedside to bedside – unlike mobile workstations.
 
DNATM (Dynamic Network Access™), which functions like a Citrix thin-client, is embedded in the Spacelabs monitor and enables full access to all applications installed on a hospital’s Citrix server. Consistent with Spacelabs’ commitment to open architecture, DNA operates on a non-proprietary infrastructure and no additional hardware is required.&nbsp; Because it’s easy to access information with DNA, clinicians can be assured of having the information needed to make critical clinical decisions as well as a convenient tool for sharing information with other caregivers – at the point-of-care.
 
“Our goal to improve the efficiency and accuracy of patient care is once again realized with the introduction of the SL2900. Not only does this new monitor support the needs of the highest acuity environments, but it delivers clinical information to where it’s needed most,” said Group President Nicholas Ong.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview SL2900.The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-04-23T21:39:15+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Telemetry Again Ranks #1]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-telemetry-again-ranks-1</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-telemetry-again-ranks-1#When:21:44:33Z</guid>
      <description><![CDATA[For immediate releaseSpacelabs Telemetry Monitors Again Rank #1

Issaquah, Wash., April 15, 2010 – According to MD Buyline’s April 2010 report, telemetry monitors from Spacelabs Healthcare have again earned the highest customer satisfaction rating, compared with scores from users of eight competing telemetry suppliers. In this most recent survey, Spacelabs ranks highest in all categories; System Performance, System Reliability, Installation/Implementation, Applications Training, Service Response Time and Service Repair Quality.
 
“The most important measure of our success is how well we serve our customers,” said Joe Davin, Group President at Spacelabs Healthcare. “Consistently achieving this top ranking clearly indicates that our continued emphasis on quality has earned the recognition of our customers.”
 
Spacelabs Healthcare pioneered telemetry in 1958 when tasked with monitoring the vital signs of NASA’s Gemini astronauts, and then was first to introduce telemetry to hospitals. Today, hospitals around the world depend on Spacelabs Healthcare’s telemetry for continuous, reliable monitoring of ambulatory patients.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s telemetry devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
 ]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-04-18T21:44:33+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Healthcare Introduces Ultraview DM3 Dual-Mode Vital Signs Monitor]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-introduces-ultraview-dm3-dual-mode-vital-signs-monitor</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-healthcare-introduces-ultraview-dm3-dual-mode-vital-signs-monitor#When:21:42:46Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Introduces the Ultraview DM3 Dual-Mode Vital Signs Monitor
 
Issaquah, Wash., April 16, 2010 – Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare’s Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.&nbsp;  
 
The latest in the Ultraview series, the new DM3 can be used in any patient care environment where basic vital signs monitoring is needed. In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients. Supplemental patient information, such as Pain Level, Patient Position (during NIBP), Site Check, and Caregiver ID, can also be specified by the user for inclusion in the patient’s record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system.&nbsp; 
 
In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance. In those instances, such as following a procedure, short-term but constant monitoring may be necessary based on variable patient acuity. 
 
“In keeping with Spacelabs’ tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products,” said Group President Nicholas Ong.
 
The Ultraview DM3 has just recently received FDA 510(k) clearance for market and sale within the United States. Plans are underway to expand marketing and sales efforts into Canada, Europe, Middle East and Africa.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview DM3. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-04-18T21:42:46+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[USCOM saves a life in the UK]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/uscom-saves-a-life-in-the-uk</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/uscom-saves-a-life-in-the-uk#When:21:48:41Z</guid>
      <description><![CDATA[Press Release
February 18th, 2010

NEW EQUIPMENT AT CHILDREN’S HOSPITAL HELPS SAVE LIVES
 
Nottingham’s Children’s Hospital has benefited from new, state-of-the-art equipment that helped save the life of a six-month-old baby within hours of being installed.
 
The £15,000 for the Ultrasonic Cardiac Output Monitor, or USCOM, was donated to Nottingham University Hospitals Charity by Councillor Barrie Cooper, the former Mayor of Rushcliffe.
 
Councillor Cooper chose NUH Charity’s Children’s Hospital fund as his ‘Charity of the Year’ during his year of office in 2008-09, and raised a total of £15,439.20.
 
The USCOM, which provides a non-invasive way of measuring the heart function of sick children, was installed in the Paediatric Intensive Care Unit (PICU) at the Queen’s Medical Centre on January 16th.
 
One of the first patients to benefit from the machine was six-month-old Abbie Sisson, who was rushed to hospital on January 16th with suspected meningitis.
 
Her mum, Charlotte Pattison, 23, from Nottingham, explained: “Abbie just wouldn’t wake up so we called NHS Direct and they sent an ambulance and she was taken to the Queen’s Medical Centre. Then a rash started to appear.
 
“When she got to the hospital she was hooked up to a load of monitors and then she was taken to intensive care where we didn’t see her for two and a half hours. Then the consultant came in and said she only had a small chance of survival. There are no words to describe how we felt.”
 
Abbie was diagnosed with meningococcal septicaemia, the blood poisoning version of meningitis, and was given just a four per cent chance of survival.
 
Dr Patrick Davies, Consultant in Paediatrics, treated Abbie and used the newly-installed USCOM to help find the right treatment for her.
 
Dr Davies explained: “The USCOM works by measuring the speed, volume, and force of blood flow coming out of the heart, which enables us to exactly define how hard the heart is working, and which aspects of its work the heart is struggling with.
 
“Once we know this, we can give the patient drugs to help the heart to support the patient’s blood pressure. We have a range of drugs we can use, which all have different actions. Previously, we had to use guesswork to choose the right drug - now we can be sure of what we use.
 
“Abbie was extremely unwell when she arrived with us with meningococcal septicaemia and was probably within minutes of a cardiac arrest. On admission, her percentage chance of death was calculated at 96%. Use of the USCOM machine helped us define the best treatment for her, and to make sure we had the right dose of the right drug at the right time.
 
“Abbie responded excellently to treatment and knowledge of exactly what was happening with her heart was an integral part of her treatment. We obviously don’t know what would have happened without the machine, but the more we know about these patients, the better.”
 
Mum Charlotte said: “Abbie made it through the night and then in the morning the consultant said he was amazed she had made such a good recovery so quickly.”
 
Abbie made a full recovery and is now back home with Charlotte, who said: “You would never know now that she was so ill – she’s giggling and really happy and absolutely perfect. The staff in the ward were absolutely amazing. The consultant, Dr Patrick Davies, was so fantastic – he has done so much for our family.”
 
Councillor Cooper visited PICU and met with Charlotte and Abbie after the baby’s recovery. Explaining why he chose to raise funds for the Children’s Hospital, he said: “I had lots of requests from lots of different charities and it was difficult choose but we thought we would like to do something for children so that’s when I got in contact with the hospitals charity.
 
“We were invited to visit the QMC and saw some of the children in the wards and that made our mind up.”
 
Fundraising events run by Councillor Cooper included concerts, lunches and a quiz night.
Nottingham University Hospitals Charity exists to support the work that takes place at Nottingham University Hospitals (NUH) Queen’s Medical Centre and City Hospital campuses.
Donations to the charity are used to enhance patient care at NUH by providing specialist equipment, medical research and staff training.
 
 
To find out more about NUH Charity, to make a donation or to get involved in fundraising, go to www.nuhcharity.org.uk.


 
Two photographs are attached – one of Barrie Cooper and Abbie Sisson, the other, from left to right, shows Charlotte Pattison and Adam Sisson, their daughter Abbie Sisson, Jean Cooper and her husband Barrie Cooper.
 
Charlotte Pattison is available for interview and photographs on request – please contact Samantha Hughes, NUH Charity Promotions Officer.
 
 
Media Contact
Samantha Hughes
Promotions Officer
Nottingham University Hospitals Charity
0115 9691169 extension 59946
Samantha.Hughes@nuh.nhs.uk
 
Notes
NUH Charity supports the work that goes on at Nottingham University Hospitals Queen’s Medical Centre and City Hospital campuses. Donations to the charity are used in four key areas:

improving patient care
enabling medical research
purchasing equipment
providing additional education and care for staff

The NHS provides core funding, but donations to NUH Charity really make a difference to patient experience by providing extras.
With almost £3 million in generous donations every year from all sectors of the community, NUH Charity has been able to work closely with Nottingham University Hospitals NHS Trust to provide these extras, making a significant difference to patients, their families, and staff within all areas of our Hospitals.

Last financial year, this money was used to support initiatives such as the purchase of new curtains for all clinical areas of the Trust; a youth room; a complementary therapy service for children; specialist nursing and midwifery training; an ultrasound scanner for problematic pregnancies; a number of items of equipment to assist in the treatment of Prostate Cancer and urological diseases; a robot used by researchers looking for ways to diagnose earlier breast and other cancers; staff awards ceremonies; as well as funding vital research and generally enhancing patient and staff care.

NUH Charity welcomes enquiries from the media about the appeals it runs, the generous gifts it receives and how donations are helping patients, their families and staff throughout NUH NHS Trust.
Our registered charity number is 1059049.

&nbsp;]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-03-02T21:48:41+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Ranks First in 2009 ServiceTrak Results]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-ranks-first-in-2009-servicetrak-results</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-ranks-first-in-2009-servicetrak-results#When:21:51:31Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Ranks Highest in Overall Service Performance According to the Industry’s Top Independent Survey
 
IMV Ranks Spacelabs Healthcare Best Overall for Service among Industry Peers for Second Time in Three Years
 
Jan. 31, 2010 – Spacelabs Healthcare, a pioneer in the field of patient monitoring, announced that the company leads the industry in overall service satisfaction. The 2009 ServiceTrak™ Patient Monitoring Systems survey by market research firm IMV Ltd., found that Spacelabs Healthcare ranks first in the industry in nine performance factors measuring service quality.&nbsp; Eighty-eight percent of respondents rated Spacelabs overall service performance as either “Very Good or Excellent”.
Spacelabs Healthcare is top-ranked in the Patient Monitoring industry for both Overall Service Performance and Service Performance Relative to Charge. Other specific areas where Spacelabs led the industry were: Sufficiency of Training to Operate &amp; Repair Equipment Diagnosing &amp; Solving Problems by Help Desk (Tech Support), Availability &amp; Value of Replacement parts, and Depot Service and Service Performance Relative to Charge.
“A customer-first philosophy is one of the guiding principles of Spacelabs Healthcare and it has helped us earn and sustain a reputation for excellence,” said Joe Davin, Spacelabs Healthcare Group President. “We are delighted that this industry survey recognizes the dedication of Spacelabs Healthcare staff to providing the highest standards of service on an everyday basis.”
 
About IMV Ltd.
 
IMV Ltd. is a healthcare market research company and has been reporting on customer satisfaction and analyzing market trends in medical and scientific products for over 20 years.&nbsp; IMV’s ServiceTrak reports are available for multiple disciplines and are based on telephone interviews conducted annually with health-care industry professionals. Respondents are selected at random and individual responses are always completely confidential.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding IMV, Ltd.. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-02-01T21:51:31+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Introduces Ultraview Enhanced Wireless Capabilities]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-introduces-ultraview-enhanced-wireless-capabilities</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-introduces-ultraview-enhanced-wireless-capabilities#When:21:58:59Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Introduces Enhanced Wireless Capabilities For Ultraview SL Portable Patient Monitors

Issaquah, WA&#8212;- Spacelabs Healthcare, an innovator in patient monitoring and connectivity solutions, has launched a new enhanced wireless feature set for the Ultraview SL2200, SL2400 and SL2600 portable patient monitors.
 
As part of the company’s resounding commitment to open connectivity standards, Spacelabs maintains wireless patient monitoring operability using a hospital’s existing wireless infrastructure while coexisting with other wireless devices. This enhanced wireless feature set enables wireless deployments in the IEEE 802.11a/b/g bands using WPA (TKIP) or IEEE 802.11i-compliant WPA2 (AES) security. Spacelabs is initially launching the Enhanced Wireless feature set within the U.S. and Canada; worldwide distribution is planned for early 2010.
 
“Spacelabs is pleased to offer a more flexible, real-time wireless monitoring solution with enhanced security to ensure fast, uninterrupted patient surveillance and data collection throughout the continuum of care,” said Deepak Chopra, Spacelabs Chief Executive Officer. “Wireless network capability enables clinicians to access and document real-time patient information even during transport, helping them make critical decisions quickly and seamlessly.&#8221;
 
The Enhanced Wireless feature set allows hospitals concerned with oversaturation by 802.11b/g wireless devices to deploy Ultraview SL wireless monitors on 802.11a which operates in the 5.4 GHz band. This band is less congested and more immune to interference from 2.4 GHz devices, such as those operating on 802.11b/g, legacy 802.11 frequency-hopping spread spectrum (FHSS), Bluetooth and microwave ovens.
 
The Enhanced Wireless feature set can be ordered at time-of-sale, or post-sale for field installation.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the wireless feature set and Ultraview SL patient monitors. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-01-19T21:58:59+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Top MDBuyline Scores for Spacelabs Holter Products]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/top-mdbuyline-scores-for-spacelabs-holter-products</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/top-mdbuyline-scores-for-spacelabs-holter-products#When:21:56:39Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Receives Top Scores for its Holter Monitoring in MDBuyline Customer Satisfaction Ratings
 
Issaquah, Wash., January 15, 2010 – Spacelabs Healthcare, a global manufacturer of Diagnostic Cardiology, Patient Monitoring and Anesthesia medical devices, is pleased to announce a top ranking for its Holter Monitoring in the latest independent MDBuyline User Satisfaction Composite Ratings.
 
Companies were evaluated by customers who use Holter technology in their patient care and Spacelabs Healthcare scored highest in the categories of system reliability and applications training. The company also achieved above average ratings in the categories of, installation/implementation, service response time and service repair quality indicating a robust and trusted line of Holter products.
 
The Diagnostic Cardiology product family of Spacelabs Healthcare originated with Del Mar Reynolds, which invented Holter technology 40 years ago. Today the company offers state-of-the-art digital Holter recorders, fast and accurate Holter analyzers, and 7-day Holter screening solutions. The latest addition to the portfolio is Sentinel, a sophisticated Cardiology Information Management Systems (CIMS) that consolidates the workflow of the entire range of noninvasive diagnostic cardiology modalities: Holter monitoring, ambulatory BP monitoring (ABPM), 12-lead Resting ECG, and Stress ECG, and Spacelabs Healthcare patient monitoring. Sentinel also interfaces to a number of other manufacturers ECG products as well. The CIMS organizes the data and stores both details and recordings in a central, networked database – saving time in searching for records and improving clinician efficiency.
 
“We are pleased that our decades-long reputation for Holter devices and powerful information management platforms are recognized and valued by our customers. Clinicians all over the word count on Spacelabs Healthcare for reliable, scalable and accurate Holter reporting and processes. We are dedicated to helping our customers improve their patient outcomes, user experience and business performance,” said Joe Davin, Group President at Spacelabs Healthcare.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s Holter and Diagnostic Cardiology devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-01-19T21:56:39+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Top MDBuyline Scores for Spacelabs Telemetry]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/top-mdbuyline-scores-for-spacelabs-telemetry</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/top-mdbuyline-scores-for-spacelabs-telemetry#When:21:54:55Z</guid>
      <description><![CDATA[For immediate releaseSpacelabs Healthcare&#8217;s Telemetry Monitors Ranked Highest In MD Buyline User Satisfaction Survey
 
Issaquah, Wash., January 18, 2010 – Spacelabs Healthcare, a leading manufacturer of patient monitoring and connectivity solutions, as well as diagnostic cardiology and anesthesia devices, has announced that it is ranked highest in telemetry monitoring according to MD Buyline’s most recent  User Satisfaction Composite Ratings.
 
In this independent survey, Spacelabs telemetry users provided the highest overall ratings compared with scores from users of eight competing telemetry suppliers. In addition, Spacelabs telemetry scored highest in System Reliability as well as Service Repair Quality.
 
“It is gratifying to know that Spacelabs telemetry users realize the inherent quality of our products as well as our extraordinary efforts to provide them with only the best service experiences. We are grateful for their confidence in our people and our technology – and tremendously proud to receive this most recent recognition”, said Joe Davin, Group President at Spacelabs Healthcare.
 
Telemetry got its start in 1958 when NASA turned to Spacelabs to meet the ultimate clinical challenge – wireless monitoring of Gemini astronauts’ vital signs. Following this achievement, Spacelabs was the first to introduce telemetry to hospitals, and today hospitals around the world depend on Spacelabs for continuous, reliable monitoring of ambulatory patients.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s telemetry devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2010-01-19T21:54:55+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Expands U.S. Coverage with Manufacturer's Rep Organization]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-expands-u.s.-coverage-with-manufacturers-rep-organization</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-expands-u.s.-coverage-with-manufacturers-rep-organization#When:22:03:15Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Expands Customer Coverage in the United States with Experienced Manufacturer’s Representative Organization
 
Issaquah WA, Nov. 2, 2009 – Spacelabs Healthcare announces the expansion of its sales coverage in the United States by contracting with a Manufacturer’s Representative organization to augment its direct sales channel. This addition of over 30  representatives will enhance the company’s ability to serve clinicians and healthcare facilities more effectively with Spacelabs’ broad portfolio of patient monitors, telemetry, connectivity solutions, anesthesia systems, diagnostic cardiology products, clinician training and award-winning service.
 
The Manufacturer’s Rep (MR) companies joining Spacelabs were part of the Phillips Healthcare Indirect Channel and were eliminated in July, 2009, when Phillips changed the structure of their selling operations. Spacelabs had been already pursuing new ways to expand its coverage and found a good match in the experience and customer focus of this group. The three companies that have joined Spacelabs are RMS Medical (Minneapolis, MN), CF Medical, Inc. (Danvers, MA) and Reliance Medical Systems (The Woodlands TX). The Direct and MR channels will work together in some states and divide other states based on geography, product mix and customer relationships.
 
MR Channel Director Theresa Stewart said, “I have managed this group of healthcare professionals for a long time and can attest to their knowledge of clinical needs and the hospital environment. We are excited to bring this background to Spacelabs, a clear leader in innovation and customer service for over 50 years. This combination of Spacelabs real-world clinical solutions and the experience of these Manufacturer’s Reps will enable us do an even better job of helping clinicians help their patients.”
 
According to Joe Davin, Spacelabs Group President, “We are very excited to expand our Customer First approach with the experience and knowledge of these three companies and this new channel. We see this action as an important step in Spacelabs’ growth and our goal of Connecting Innovation with Care.”
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Athens Regional Medical Center contract to purchase patient monitoring systems from Spacelabs Healthcare. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-11-09T22:03:15+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Athens Regional Medical Center expands partnership with Spacelabs]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/athens-regional-medical-center-expands-partnership-with-spacelabs</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/athens-regional-medical-center-expands-partnership-with-spacelabs#When:22:01:25Z</guid>
      <description><![CDATA[For immediate release
October 3, 2009ATHENS REGIONAL MEDICAL CENTER EXPANDS HEALTHCARE PARTNERSHIP WITH SPACELABS HEALTHCARE; WILL NOW INCLUDE MAIN OR, L&amp;D OR AND PACU
 
Issaquah, Wash., and Athens, GA – Athens Regional Medical Center (ARMC) has enhanced its dynamic relationship with Spacelabs Healthcare by purchasing additional medical technology for new care areas. Part of Athens Regional Health Services, ARMC is a 315-bed regional referral center, serving a 17-county area in northeast Georgia.
 
In July 2009, ARMC purchased patient monitoring equipment for their Critical Care and Cardiovascular Intensive Care units. Products included Spacelabs’ modular Ultraview™ SL2800-series bedside monitors, which offer complete monitoring and workstation performance in a single package. Internal modules allow the hospital to monitor an array of vital signs, including a complete suite of ECG parameters, non-invasive blood pressure, temperature and oxygen saturation. Vital sign measurements can be configured at each monitor for a specific patient by choosing parameters from the modules. EtCO2 monitoring will be provided by an Ultraview Multigas analyzer. In addition, Ultraview SL3800 central monitors will capture monitored data from hardwired and wireless patient monitors as well as patient-worn telemetry units, and display the data at a central workstation. The information is then stored and can be transmitted to the hospital information system or to another system, increasing the efficiency of the clinical staff.
 
ARMC also purchased ICS G2, a completely integrated application suite that makes their CCU and CVICE patient data accessible anywhere on the hospital network as a single, consolidated patient record. The ICS G2 system has an extensive set of clinical capabilities developed in conjunction with clinicians to improve efficiency, functionality and flow of clinical information. These tools are designed to help lower costs, reduce lengths of stay and improve outcomes.
 
“Ultraview SL patient monitors offer fast access to comprehensive patient information where and when it’s needed,” said Joseph Davin, President, Spacelabs Healthcare North America. “Our monitors can help speed and support clinical decisions at Athens Regional Medical Center, which can improve response time, advance patient care and enhance patient safety.”
 
Relationship expanded in September
The expansion of the relationship was announced this week. ARMC will equip their main and Labor &amp; Delivery Operating Rooms, Preoperative Short Stay (POSS) unit, endoscopy care area, outpatient surgery center, PACU and other perioperative care areas with medical technology from Spacelabs. The medical center will also upgrade their existing Spacelabs preoperative surgery with new technology.
 
The new order encompasses the full range of Spacelabs patient monitoring technology, including:Ultraview 2400, Ultraview 2600, Ultraview 2700 and Ultraview 2800 monitors
Ultraview 3800 central monitors
Ultraview Multigas analyzers
ICS G2 application suite with HL7 interface

Spacelabs will facilitate tying all technology into ARMC’s bar coding system that simplifies patient admission and allows full disclosure throughout the care process.
 
“We are excited about the prospects of expanding our partnership with Spacelabs,” said Dee Burkett, vice president of professional services at Athens Regional Medical Center. “This technology will allow Athens Regional Medical Center to continue to provide a consistently high level of patient care, yet enable us to simplify the healthcare process to encourage efficient use of our clinical staff.”About Athens Regional Medical Center
Athens Regional Medical Center is a 315-bed full service regional referral center and is part of Athens Regional Health Services, an integrated system that provides for the healthcare needs of a 17-county service area in Northeast Georgia. Athens Regional has recently expanded its Emergency Department and revamped its Radiology Department, Labor and Deliver and Mother - Baby Units. More expansion is underway that will bring the number of licensed beds to 360 and expand its surgical department with four new operating rooms, pre-and post-operative areas, cardiovascular, endoscopy and laboratory services.
 
Athens Regional features nationally acclaimed, comprehensive cardiac, vascular and thoracic procedures including open heart surgery; cardiac catheterization and vascular labs; a full-spectrum of advanced surgical procedures; minimally invasive surgeries; a neurosurgery unit; a stroke center; a free-standing outpatient radiology center and outpatient surgery center; adult and children’s rehabilitation services; diagnostic and therapeutic oncology; Magnetic Resonance Imaging (MRI) and PET/CT Scanner; a neonatal intensive care unit, the Loran Smith Center for Cancer Support, the Breast Health Center and an on-site Spine Institute. For more information, visit their website: www.armc.org.
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Athens Regional Medical Center contract to purchase patient monitoring systems from Spacelabs Healthcare. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-11-09T22:01:25+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Sentinel Launches in US]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/sentinel-launches-in-us</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/sentinel-launches-in-us#When:22:06:44Z</guid>
      <description><![CDATA[For immediate release

Spacelabs Healthcare Launches Sentinel Cardiology Information Management System with Patient Monitoring Integration in the United States
 
Issaquah, Wash., September 11, 2009 – Spacelabs Healthcare is pleased to announce the U.S. launch of Sentinel, a sophisticated Cardiology Information Management Systems (CIMS), that will facilitate analysis and reporting while also improving efficiency and eliminating errors. 

Sentinel integrates reports from the entire range of noninvasive diagnostic cardiology modalities: Holter monitoring, ambulatory BP monitoring (ABPM), 12-lead Resting ECG, and ECG stress testing. It organizes the data and stores both details and recordings in a central, networked database – saving time in searching for records and improving clinician efficiency.

As a fully scalable solution, Sentinel is designed for use either in a single station configuration, such as a physician’s office, or for a large multi-centered hospital.&nbsp; Networkable and compatible with existing 12-Lead ECG carts, Sentinel allows clinicians immediate access to the complete information for a given patient, including historic ECG data, which can be viewed at workstations or via the web from any location through secured software applications.&nbsp; Designed to integrate with existing EMR and Hospital Information Systems, it allows seamless connectivity of patient records from admission through recording, diagnosis, billing and discharge.

Integrating cardiology information management with patient monitoring, Sentinel receives and stores 12-lead ECG reports from Spacelabs Ultraview® SL patient monitors as well as from a wide range of resting 12-lead ECG systems. The 12-lead reports can be reviewed and confirmed from any authorized PC client on the hospital network, as well as from the Ultraview SL patient monitors utilizing WinDNA® technology.

Joseph Davin, Spacelabs Group President, North American Operations, said, “Sentinel further illustrates Spacelabs’ commitment to providing caregivers with flexible, innovative solutions that make the most of their existing equipment and IT investments in Diagnostic Cardiology and Acute Care Monitoring technologies.”

About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding opening of the Company’s anesthesia and ventilation office in Madison. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-09-18T22:06:44+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[dabl, Ltd., and Spacelabs (UK and Italy) Form New Partnership]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/dabl-ltd.-and-spacelabs-uk-and-italy-form-new-partnership</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/dabl-ltd.-and-spacelabs-uk-and-italy-form-new-partnership#When:22:04:06Z</guid>
      <description><![CDATA[dabl Ltd  and Spacelabs Healthcare (UK and Italy) form new partnership to  prevent thousands of strokes and heart attacks caused by high blood pressure
 
07 September 2009:&nbsp; dabl Ltd, the global leader in the development and supply of cardiovascular disease management systems, today announced that it has signed an agreement with Spacelabs Healthcare (UK and Italy), a leading international medical equipment and services company.&nbsp; Spacelabs will now promote and offer for sale, the dabl ABPM 24 hour blood pressure software along with their ambulatory blood pressure monitors to GPs and pharmacies making this life-saving method of blood pressure measurement readily available to all. 

Uncontrolled blood pressure is one of the highest risk factors (approx. 40%) for strokes, heart attacks, cognitive impairment and a range of other cardiovascular conditions.&nbsp; Medical research now shows that relying solely on a one-off blood pressure test is outdated and can be highly inaccurate.&nbsp; Current hypertension guidelines specify that the most accurate measurement for blood pressure is over a 24-hour period, commonly called ABPM (Ambulatory Blood Pressure Monitoring). 

Prof Eoin O’Brien, a leading international expert, is a strong supporter of 24-hour blood pressure monitoring and believes that “every patient suspected of having hypertension should have a 24-hour blood pressure measurement to confirm or refute the diagnosis, and every patient with uncontrolled hypertension should have an ABPM repeated as necessary until 24-hour control of blood pressure is achieved”.&nbsp; This would substantially reduce the incidence of stroke and heart attack worldwide.&nbsp; 

The dabl ABPM software automatically interprets the data making this important investigation accessible to general practice and pharmacy and improving the overall standard of reporting.&nbsp; The system is used in over 1,000 clinics and pharmacies worldwide and is considered the gold standard in 24-hour ABPM by the medical experts. 

Bill Rickard, Managing Director of dabl Ltd, commented that &#8220;As part of our global strategy to develop key channel partners we are very pleased with our agreement with Spacelabs Healthcare (UK and Italy), who are also market leaders in their own area of expertise.&#8221; 

According to Ian Harper, UK Managing Director of Spacelabs Healthcare, “Spacelabs has long been considered the ‘gold standard’ equipment provider for ABPM equipment within the Acute / Hospital markets.&nbsp; This new partnership with dabl Ltd will ensure that primary healthcare practitioners and local pharmacies are also able to provide fast, reliable and interpreted ABPM reports to dramatically help improve patient care and management”.

The combined 24-hour blood pressure monitoring solution from dabl and Spacelabs Healthcare UK and Italy maximizes the excellence of both companies for the benefit of local healthcare providers and their patients, and provides a real solution to address the potential errors and inaccuracies that can be associated with traditional blood pressure measurement, thus allowing for improved blood pressure control that will prevent stroke and heart attack.

Ends/

Tags: 
24 hour blood pressure, blood pressure software, ambulatory blood pressure monitor, ambulatory blood pressure monitoring, uncontrolled blood pressure, hypertension guidelines, 24 hour ABPM

Further information:
Paula O’Sullivan
dabl Ltd &nbsp;  &nbsp;  &nbsp;  &nbsp;  &nbsp;  &nbsp;  &nbsp;  &nbsp;  &nbsp; 
Tel:&nbsp; +353 1 2780247
 
About dabl Ltd
dabl Ltd (www.dabl.ie) is a leading developer and provider of expert healthcare management systems and research tools for the prevention and management of stroke, heart attack, high blood pressure, anticoagulation and a range of other cardiovascular conditions. 
 
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding dabl products and their launch. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-09-18T22:04:06+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs expands release of USCOM monitor]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-expands-release-of-uscom-monitor</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-expands-release-of-uscom-monitor#When:22:07:26Z</guid>
      <description><![CDATA[For immediate release
August 24, 2009Spacelabs Healthcare Expands International Distribution of USCOM Cardiac Output Monitor

Issaquah, Washington, August 25, 2009 – Spacelabs Healthcare today announced the launch of the Ultrasonic Cardiac Output Monitor (USCOM) in several new geographies, including Latin America, Africa, Europe, Australia and Middle East. USCOM’s unique and totally non-invasive method of cardiac monitoring provides an accurate, safe and efficient way of measuring how well the heart is functioning.

“We are pleased to see the strong interest in this new technology and are working hard to spread the news globally of its success in assisting with better patient care”, said Joseph Davin, President, Spacelabs Healthcare North American Operations.

USCOM is the only non-invasive device to provide beat-to-beat performance of both the left and right side of the heart. Portable and user-friendly, USCOM revolutionizes care in all areas, including Emergency, Intensive Care, and general practice. However, USCOM’s most dramatic impact may well be in pediatric intensive care, a population that traditionally could not be safely monitored due to the invasiveness of conventional cardiac output technologies. Now, with USCOM, infants and children can be monitored non-invasively, without risk of infection. 

According to Dr. Nelson Hernandez, pediatric intensive care physician at Hospital Calvo Mackenna, Santiago, Chile, “USCOM is easy to use and reliable, an excellent tool to assess septic shock in pediatric patients.”

Added Australia’s Dr. Brendan Smith, “This machine is saving lives. No two ways about it.”

About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the USCOM product and its launch. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-08-27T22:07:26+00:00</dc:date>
    </item>

    <item>
      <title><![CDATA[Spacelabs Opens Anesthesia Office in Madison, Wisconsin]]></title>
      <link>http://www.spacelabshealthcare.com/de/company/news/spacelabs-opens-anesthesia-office-in-madison-wisconsin</link>
      <guid>http://www.spacelabshealthcare.com/de/company/news/spacelabs-opens-anesthesia-office-in-madison-wisconsin#When:22:09:15Z</guid>
      <description><![CDATA[For immediate release
August 3, 2009

SPACELABS HEALTHCARE OPENS ANESTHESIA DELIVERY AND VENTILATION OFFICE IN MADISON, WIS.
 
Issaquah, Wash. – Spacelabs Healthcare, Inc., a manufacturer of medical equipment for the global healthcare market, has opened a U.S. office dedicated to anesthesia delivery and ventilation solutions. The new office, located in Madison, Wisconsin, increases the company’s U.S. presence with an expanded R&amp;D group and state-of-the-art engineering lab.
 
Building on its Blease Medical subsidiary’s 60 years of serving the healthcare community with anesthesia delivery solutions, Spacelabs Healthcare plans to use this new facility to reach more customers with an even broader portfolio. The new office is part of Spacelabs’ strategic decision to place an increased focus on the U.S. anesthesia market, while retaining its European expertise. Spacelabs’ anesthesia delivery systems incorporate the latest technology and are manufactured in Issaquah, Washington.
 
“The new R&amp;D facility and employees demonstrate Spacelabs’ commitment to the U.S. market,” said Gary Grenter, Spacelabs’ Anesthesia Delivery &amp; Ventilation President. “Our dedicated group has the unique knowledge and experience base to provide anesthesia delivery and ventilation solutions that meet the new challenges of a rapidly changing domestic market.”
 

About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding opening of the Company’s anesthesia and ventilation office in Madison. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.]]></description>
      <dc:subject><![CDATA[]]></dc:subject>
      <dc:date>2009-08-07T22:09:15+00:00</dc:date>
    </item>

    
    </channel>
</rss>
